The Europe Atrial Fibrillation Market would witness market growth of 5.4% CAGR during the forecast period (2022-2028).
Medications to lower heart rate to a range close to normal (rate control) or change the rhythm to normal sinus rhythm are frequently used to treat AF (known as rhythm control). If a person is unstable, electrical cardioversion, which can return AF to a normal heart rhythm, is frequently required. Some people's recurrences may be prevented with ablation. Blood-thinning medications are not always necessary for people with AF who have a low risk of stroke, however, some medical professionals may recommend aspirin or an anti-clotting drug.
Experts often advise using an anti-clotting medicine for people at higher than low risk. Warfarin and other direct oral anticoagulants are examples of anticoagulant medicines. The majority of persons have an increased risk of stroke. These drugs lower the risk of stroke but raise the incidence of serious bleeding. Heart-rate-related symptoms are frequently seen with AF. Palpitations, exercise intolerance, and occasionally anginal difficulty breathing can all be symptoms of rapid and irregular heart rates.
Rapid and irregular heart rates can also cause the heart to beat too quickly, irregularly, or skip beats. Congestive heart failure symptoms including exhaustion, breathlessness, or edema are further potential signs. Sometimes the abnormal heart rhythm (arrhythmia) is only discovered after a stroke or transient ischemic attack first occurs (TIA). Because AF frequently doesn't generate symptoms, it is fairly unusual for someone to learn they have it via a normal physical examination or EKG.
Cardiovascular disorders are the main cause of mortality. They encompass a wide range of medical conditions that affect the vascular system (the heart and blood vessels), frequently as a result of atherosclerosis, the abnormal build-up of plaque on the inner walls of an individual's arteries that is made up, among other things, of cholesterol or fatty substances. The several EU Member States have seen a decline in the number of fatalities brought on by circulatory system disorders in recent years. Increased screening, new surgical techniques, the use of new medications, and changes in patients' lifestyles might all have contributed to these developments, at least in part (for example, a reduction in the number of smokers).
The Germany market dominated the Europe Atrial Fibrillation Market by Country in 2021; thereby, achieving a market value of $174.8 million by 2028. The UK market would exhibit a CAGR of 4.5% during (2022 - 2028). Additionally, The France market is anticipated to grow at a CAGR of 6.2% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on Type, the market is segmented into Surgical and Non-Surgical. Based on Technology, the market is segmented into Radiofrequency, Laser, Cryotherapy, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Atrial Fibrillation Market will Hit $2.7 Billion by 2028, at a CAGR of 9.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, Abbott Laboratories, Medtronic PLC, BIOTRONIK SE & Co. KG, Koninklijke Philips N.V., Siemens Healthineers AG (Siemens AG) and AtriCure, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospitals
- Specialty Clinics
- Others
By Type
By Technology
- Radiofrequency
- Laser
- Cryotherapy
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- Abbott Laboratories
- Medtronic PLC
- BIOTRONIK SE & Co. KG
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- AtriCure, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Atrial Fibrillation Market, by End User
1.4.2 Europe Atrial Fibrillation Market, by Type
1.4.3 Europe Atrial Fibrillation Market, by Technology
1.4.4 Europe Atrial Fibrillation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jun – 2022, Jan) Leading Players
Chapter 4. Europe Atrial Fibrillation Market by End User
4.1 Europe Hospitals Market by Country
4.2 Europe Specialty Clinics Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Atrial Fibrillation Market by Type
5.1 Europe Surgical Market by Country
5.2 Europe Non-Surgical Market by Country
Chapter 6. Europe Atrial Fibrillation Market by Technology
6.1 Europe Radiofrequency Market by Country
6.2 Europe Laser Market by Country
6.3 Europe Cryotherapy Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Atrial Fibrillation Market by Country
7.1 Germany Atrial Fibrillation Market
7.1.1 Germany Atrial Fibrillation Market by End User
7.1.2 Germany Atrial Fibrillation Market by Type
7.1.3 Germany Atrial Fibrillation Market by Technology
7.2 UK Atrial Fibrillation Market
7.2.1 UK Atrial Fibrillation Market by End User
7.2.2 UK Atrial Fibrillation Market by Type
7.2.3 UK Atrial Fibrillation Market by Technology
7.3 France Atrial Fibrillation Market
7.3.1 France Atrial Fibrillation Market by End User
7.3.2 France Atrial Fibrillation Market by Type
7.3.3 France Atrial Fibrillation Market by Technology
7.4 Russia Atrial Fibrillation Market
7.4.1 Russia Atrial Fibrillation Market by End User
7.4.2 Russia Atrial Fibrillation Market by Type
7.4.3 Russia Atrial Fibrillation Market by Technology
7.5 Spain Atrial Fibrillation Market
7.5.1 Spain Atrial Fibrillation Market by End User
7.5.2 Spain Atrial Fibrillation Market by Type
7.5.3 Spain Atrial Fibrillation Market by Technology
7.6 Italy Atrial Fibrillation Market
7.6.1 Italy Atrial Fibrillation Market by End User
7.6.2 Italy Atrial Fibrillation Market by Type
7.6.3 Italy Atrial Fibrillation Market by Technology
7.7 Rest of Europe Atrial Fibrillation Market
7.7.1 Rest of Europe Atrial Fibrillation Market by End User
7.7.2 Rest of Europe Atrial Fibrillation Market by Type
7.7.3 Rest of Europe Atrial Fibrillation Market by Technology
Chapter 8. Company Profiles
8.1 Johnson & Johnson
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental &Regional Analysis
8.1.4 Research & Development Expenses
8.2 MicroPort Scientific Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Approvals and Trials:
8.3 Medtronic PLC
8.3.1 Company overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.4.5.3 Approvals and Trials:
8.4.6 SWOT Analysis
8.5 BIOTRONIK SE & Co. KG
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Approvals and Trials:
8.6 Abbott Laboratories
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Approvals and Trials:
8.6.6 SWOT Analysis
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.7.5.3 Geographical Expansions:
8.8 Siemens Healthineers AG (Siemens AG)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Product Launches and Product Expansions:
8.8.5.2 Acquisition and Mergers:
8.8.6 SWOT Analysis
8.9 AtriCure, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.9.5.2 Acquisition and Mergers:
8.9.5.3 Approvals and Trials:
TABLE 1 Europe Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 2 Europe Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Atrial Fibrillation Market
TABLE 4 Product Launches And Product Expansions – Atrial Fibrillation Market
TABLE 5 Acquisition and Mergers – Atrial Fibrillation Market
TABLE 6 Approvals and Trials – Atrial Fibrillation Market
TABLE 7 Europe Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 8 Europe Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 9 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Specialty Clinics Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Specialty Clinics Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 16 Europe Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 17 Europe Surgical Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Surgical Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Non-Surgical Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Non-Surgical Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 22 Europe Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 23 Europe Radiofrequency Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Radiofrequency Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Laser Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Laser Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Cryotherapy Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Cryotherapy Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Atrial Fibrillation Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Atrial Fibrillation Market by Country, 2022 - 2028, USD Million
TABLE 33 Germany Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 34 Germany Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 35 Germany Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 36 Germany Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 37 Germany Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 38 Germany Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 39 Germany Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 40 Germany Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 41 UK Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 42 UK Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 43 UK Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 44 UK Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 45 UK Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 46 UK Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 47 UK Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 48 UK Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 49 France Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 50 France Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 51 France Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 52 France Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 53 France Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 54 France Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 55 France Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 56 France Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 57 Russia Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 58 Russia Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 59 Russia Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 60 Russia Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 61 Russia Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 62 Russia Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 63 Russia Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 64 Russia Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 65 Spain Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 66 Spain Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 67 Spain Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 68 Spain Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 69 Spain Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 70 Spain Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 71 Spain Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 72 Spain Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 73 Italy Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 74 Italy Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 75 Italy Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 76 Italy Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 77 Italy Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 78 Italy Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 79 Italy Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 80 Italy Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 81 Rest of Europe Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 82 Rest of Europe Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 83 Rest of Europe Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 84 Rest of Europe Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 85 Rest of Europe Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 86 Rest of Europe Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 87 Rest of Europe Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 88 Rest of Europe Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 89 Key information – Johnson & Johnson
TABLE 90 key Information – MicroPort Scientific Corporation
TABLE 91 Key Information – Medtronic PLC
TABLE 92 key Information – Boston Scientific Corporation
TABLE 93 Key Information – BIOTRONIK SE & Co. KG
TABLE 94 Key Information – Abbott Laboratories
TABLE 95 Key Information – Koninklijke Philips N.V.
TABLE 96 Key Information – Siemens Healthineers AG
TABLE 97 Key Information – AtriCure, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jun – 2022, Jan) Leading Players
FIG 5 Recent strategies and developments: MicroPort Scientific Corporation
FIG 6 Swot analysis: Medtronic plc
FIG 7 Recent strategies and developments: Boston Scientific Corporation
FIG 8 SWOT Analysis: Boston Scientific Corporation
FIG 9 Swot analysis: Abbott laboratories
FIG 10 Recent strategies and developments: Koninklijke Philips N.V.
FIG 11 Recent strategies and developments: Siemens Healthineers AG
FIG 12 Swot analysis: Siemens AG
FIG 13 Recent strategies and developments: AtriCure, Inc.